Diversified Trust Co Reduces Position in Stryker Co. (NYSE:SYK)

Diversified Trust Co lessened its holdings in shares of Stryker Co. (NYSE:SYK) by 6.9% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 6,573 shares of the medical technology company’s stock after selling 488 shares during the quarter. Diversified Trust Co’s holdings in Stryker were worth $1,352,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also modified their holdings of the company. Norges Bank acquired a new position in Stryker during the fourth quarter worth $474,132,000. FMR LLC raised its position in shares of Stryker by 13.4% during the first quarter. FMR LLC now owns 6,728,182 shares of the medical technology company’s stock worth $1,328,951,000 after acquiring an additional 793,560 shares during the last quarter. Ellis Investment Partners LLC raised its position in shares of Stryker by 19,658.9% during the first quarter. Ellis Investment Partners LLC now owns 367,318 shares of the medical technology company’s stock worth $367,000 after acquiring an additional 365,459 shares during the last quarter. Deutsche Bank AG raised its position in shares of Stryker by 66.2% during the fourth quarter. Deutsche Bank AG now owns 863,390 shares of the medical technology company’s stock worth $135,330,000 after acquiring an additional 343,913 shares during the last quarter. Finally, Geode Capital Management LLC raised its position in shares of Stryker by 6.5% during the fourth quarter. Geode Capital Management LLC now owns 3,665,205 shares of the medical technology company’s stock worth $573,387,000 after acquiring an additional 224,785 shares during the last quarter. Institutional investors and hedge funds own 73.59% of the company’s stock.

A number of equities research analysts have recently weighed in on SYK shares. ValuEngine upgraded Yirendai from a “strong sell” rating to a “sell” rating in a research report on Friday, May 3rd. Deutsche Bank raised their target price on Texas Instruments from $100.00 to $110.00 and gave the stock a “hold” rating in a research report on Wednesday, April 24th. Svb Leerink reaffirmed an “outperform” rating on shares of Stryker in a research report on Wednesday, July 10th. Robert W. Baird lowered their target price on Waters from $211.00 to $209.00 and set a “neutral” rating for the company in a research report on Wednesday, April 24th. Finally, Barclays raised their target price on Zimmer Biomet from $113.00 to $117.00 and gave the stock an “underweight” rating in a research report on Monday, April 15th. Four research analysts have rated the stock with a hold rating and eighteen have issued a buy rating to the company. The company has a consensus rating of “Buy” and an average price target of $202.46.

In other news, CFO Glenn S. Boehnlein sold 2,700 shares of the company’s stock in a transaction on Wednesday, May 8th. The shares were sold at an average price of $188.21, for a total value of $508,167.00. Following the transaction, the chief financial officer now owns 23,333 shares of the company’s stock, valued at $4,391,503.93. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, VP Bijoy Sagar sold 2,000 shares of the company’s stock in a transaction on Monday, May 6th. The stock was sold at an average price of $190.43, for a total transaction of $380,860.00. Following the completion of the transaction, the vice president now directly owns 3,350 shares in the company, valued at approximately $637,940.50. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 18,698 shares of company stock valued at $3,643,227. 7.20% of the stock is currently owned by company insiders.

Shares of SYK traded up $0.41 during trading hours on Thursday, hitting $213.98. The stock had a trading volume of 12,909 shares, compared to its average volume of 900,715. The company has a quick ratio of 1.30, a current ratio of 2.12 and a debt-to-equity ratio of 0.68. The business’s 50 day moving average is $203.18. The firm has a market cap of $78.12 billion, a price-to-earnings ratio of 29.19, a P/E/G ratio of 2.53 and a beta of 0.87. Stryker Co. has a 1-year low of $144.75 and a 1-year high of $213.72.

Stryker (NYSE:SYK) last issued its earnings results on Tuesday, April 23rd. The medical technology company reported $1.88 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.84 by $0.04. The company had revenue of $3.52 billion during the quarter, compared to the consensus estimate of $3.51 billion. Stryker had a return on equity of 26.72% and a net margin of 25.38%. The firm’s revenue for the quarter was up 8.5% compared to the same quarter last year. During the same period last year, the business posted $1.68 EPS. On average, research analysts forecast that Stryker Co. will post 8.15 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Wednesday, July 31st. Stockholders of record on Friday, June 28th will be paid a $0.52 dividend. The ex-dividend date is Thursday, June 27th. This represents a $2.08 annualized dividend and a dividend yield of 0.97%. Stryker’s dividend payout ratio is presently 28.45%.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical devices for use in various medical specialties.

Featured Story: Why do earnings reports matter?

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Co. (NYSE:SYK).

Institutional Ownership by Quarter for Stryker (NYSE:SYK)

Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.